Dmitrii V. Kalinin
Siberian Branch
Novosibirsk, NVS, Russian Federation
Novosibirsk, NVS, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Recent advances in factor XII(a) inhibitors: an updated patent landscape (2020-present).
Journal: Expert opinion on therapeutic patents
Published: February 05, 2026
Collaborative Synthesis for Neglected Diseases through the Open Synthesis Network: Structure-Activity Relationships of Arylaminopyrazoles as Chagas Disease Treatments.
Journal: ACS infectious diseases
Published: August 11, 2025
Piperazine-based P2X4 receptor antagonists.
Journal: Archiv der Pharmazie
Published: November 04, 2024
Biological evaluation of semi-synthetic isoindolinone isomers produced by Stachybotrys chartarum.
Journal: Frontiers in fungal biology
Published: September 11, 2024
Pyrazinyl-Substituted Aminoazoles as Covalent Inhibitors of Thrombin: Synthesis, Structure, and Anticoagulant Properties.
Journal: ACS pharmacology & translational science
Published: August 26, 2024
N-Pyrazolyl- and N-Triazolylamines and -Ureas as Antileishmanial and Antitrypanosomal Drugs.
Journal: ChemMedChem
Published: March 27, 2024
Total synthesis of (±)-auranthine confirmed its refined structure.
Journal: RSC advances
Published: November 02, 2023
An automated analysis method enabling the screening of covalent thrombin and factor XIIa inhibitors via liquid chromatography-mass spectrometry.
Journal: Drug testing and analysis
Published: June 11, 2023
Amide-functionalized 1,2,4-Triazol-5-amines as Covalent Inhibitors of Blood Coagulation Factor XIIa and Thrombin.
Journal: ACS pharmacology & translational science
Published: October 21, 2022
Pyrazole-Based Thrombin Inhibitors with a Serine-Trapping Mechanism of Action: Synthesis and Biological Activity.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 06, 2022
Last Updated: 09/26/2026